300,000+ Patients Supported with Impella® Heart Pumps
Patients and Caregivers
Protected PCI can be a safe treatment option to address severe coronary artery disease or advanced heart failure.
Health Care Professionals
Explore clinical data, educational opportunities and resources regarding the latest breakthroughs in cardiac and respiratory research.
First Patient Enrolled in Abiomed’s RECOVER IV Randomized Controlled Trial of Impella® as a Therapy for AMI Cardiogenic Shock
November 27, 2023
Abiomed to Highlight Data Analysis Identifying Complex Clinical Profile of Patients Receiving Impella® Supported HRPCI at TCT Symposium
October 23, 2023